- 公司资讯
- 智通财经APP | 2024年03月18日 09:00NASH药物市场预计到2035年将超过480亿美元 诺和诺德(NVO.US)和礼来(LLY.US)等公司开始布局
- finviz | 2022年06月21日 20:00Galectin Therapeutics Announces 2 Liver Cirrhosis Scientific Presentations at the EASL International Liver Congress 2022
- finviz | 2022年05月23日 20:00Galectin Therapeutics to Present in Upcoming H.C. Wainwright Global Investment Conference and the 5th Global NASH Congress
- finviz | 2022年05月16日 20:00Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2022 and Provides Business Update
- finviz | 2022年05月11日 23:20Catalyst Pharmaceuticals (CPRX) Q1 Earnings Miss, Revenues Up Y/Y
- finviz | 2022年05月03日 20:30Nano Dimensions Preliminary Q1/2022 Revenues: Approximately $10.5 Million
- finviz | 2022年04月15日 19:20Is Galectin Therapeutics Inc. (NASDAQ:GALT) Popular Amongst Insiders?
- finviz | 2022年04月14日 20:00Galectin Therapeutics Reports the Positive Outcome of the First Data and Safety Monitoring Board for NAVIGATE, its Seamless, Adaptive Phase 2b/3 Study of Belapectin in Patients with Liver Cirrhosis Caused by Non-Alcoholic Steatohepatitis
- finviz | 2022年03月31日 20:00Galectin Therapeutics Reports 2021 Financial Results and Provides Business Update
- finviz | 2022年01月06日 20:00Galectin Therapeutics to Present at the H.C. Wainwright BioConnect Conference
- finviz | 2021年12月21日 20:00Galectin Therapeutics Announces Closing of $10 Million in Debt Financing from Its Chairman, Richard E. Uihlein
- finviz | 2021年12月13日 20:00Galectin Therapeutics Discusses Corporate Transformation, Progress of NAVIGATE Trial and Outlines Strategy for Potential Phase 2 Cancer Immunotherapy Trial at Annual Meeting
- finviz | 2021年11月15日 20:00Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2021, and Provides Business Update
- finviz | 2021年11月06日 04:24UPDATE Galectin Therapeutics to Present Six Scientific Abstracts at The Liver Meeting 2021, Hosted by the AASLD
- finviz | 2021年10月27日 20:00Galectin Pharmaceuticals to Present Six Scientific Abstracts at The Liver Meeting 2021, Hosted by the AASLD
- finviz | 2021年10月06日 03:39UPDATE: Galectin Therapeutics to Participate in the H.C. Wainwright 5th Annual NASH Investor Conference on October 12, 2021
首页
上页
下页